Quality by Design (QbD) is now the standard for generic drug development, replacing outdated testing methods with science-based control. Learn how QbD improves bioequivalence, cuts approval times, and reduces costs-while avoiding common pitfalls.
read more
Bioequivalence for inhalers, patches, and injections ensures generic drugs deliver medicine as effectively as brand-name versions. Unlike pills, these systems require detailed testing of particle size, release rates, and delivery mechanics to guarantee safety and performance.
read more